Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Melanoma

Free Subscription Articles published in J Am Acad Dermatol Retrieve available abstracts of 275 articles: HTML format

Single Articles

April 2024
1. MONNIER J, Gouabou Foahom AC, Serdi M, Collenne J, et al
   Automated melanoma detection. An algorithm inspired from human intelligence characterizing disordered pattern of melanocytic lesions improving a convolutional neural network.
   J Am Acad Dermatol. 2024 Apr 11:S0190-9622(24)00630.
   PubMed    
   
   
   
2. WANG E, Ahad T, Liu YA, Lee TK, et al
   Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
   J Am Acad Dermatol. 2024;90:759-766.
   PubMed     Abstract available
   
   
   
3. COHEN Y, Jaberi M, Litvinov IV, Shamout Y, et al
   Novel suturing technique for reduced electrocautery in excisional procedures for non-melanoma skin cancer.
   J Am Acad Dermatol. 2024;90:e131-e132.
   PubMed    
   
   
   March 2024
4. FUNCHAIN P, Ni Y, Heald B, Bungo B, et al
   Germline Cancer Susceptibility in Individuals with Melanoma.
   J Am Acad Dermatol. 2024 Mar 19:S0190-9622(24)00504.
   PubMed     Abstract available
   
   
   
5. BANNER L, Rohan TZ, Zachian R, Gross T, et al
   Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A SEER database analysis.
   J Am Acad Dermatol. 2024 Mar 19:S0190-9622(24)00505.
   PubMed    
   
   
   
6. MATTHEWS NH, Hamad J, Henderson JB, Weinstock MA, et al
   Projected burden of melanoma clinical surveillance in the United States.
   J Am Acad Dermatol. 2024 Mar 8:S0190-9622(24)00476.
   PubMed    
   
   
   
7. TUPPER CJ, Clausen MC, Cogua LM, Silberstein PT, et al
   Improved Survival Outcomes for Melanoma of Unknown Primary in the Era of Novel Therapies: A Population-Based Retrospective Analysis.
   J Am Acad Dermatol. 2024 Mar 6:S0190-9622(24)00446.
   PubMed    
   
   
   
8. NEALE H, Plumptre I, Belazarian L, Wiss K, et al
   Guidance on screening magnetic resonance imaging decisions for congenital melanocytic nevi.
   J Am Acad Dermatol. 2024;90:e107-e108.
   PubMed    
   
   
   
9. GRANT-KELS JM
   JAAD Game Changer: Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society.
   J Am Acad Dermatol. 2024;90:674.
   PubMed    
   
   
   February 2024
10. GIULINI M, Goldust M, Grabbe S, Ludwigs C, et al
    Combining artificial intelligence and human expertise for more accurate dermoscopic melanoma diagnosis: A 2-session retrospective reader study.
    J Am Acad Dermatol. 2024 Feb 29:S0190-9622(24)00307.
    PubMed    
    
    
    
11. TORTORELLO GN, Li EH, Sharon CE, Shafique N, et al
    Pathologic Characteristics and Clinical Outcomes of Primary Dermal Melanoma.
    J Am Acad Dermatol. 2024 Feb 22:S0190-9622(24)00401.
    PubMed    
    
    
    
12. HUANG Y, Fleming P, Fung K, Chan AW, et al
    Association between dermatology follow-up and melanoma survival: a population-based cohort study.
    J Am Acad Dermatol. 2024 Feb 16:S0190-9622(24)00372.
    PubMed     Abstract available
    
    
    
13. MORR C, Jade Prechtel T, Hardacker R, Bell M, et al
    Impact of skin cancer screening on melanoma thickness and stage.
    J Am Acad Dermatol. 2024 Feb 13:S0190-9622(24)00348.
    PubMed    
    
    
    
14. KYE Y, Zhao G, Guhan S, Nunes D, et al
    Research letter: BRAF-inhibitor induced panniculitis - A systematic review.
    J Am Acad Dermatol. 2024;90:420-423.
    PubMed    
    
    
    January 2024
15. KOOPER-JOHNSON S, Kasthuri V, Homer A, Nguyen BM, et al
    Higher Risk of Melanoma-related Deaths for Patients Residing in Rural Counties: A Surveillance, Epidemiology, and End Results Program Study.
    J Am Acad Dermatol. 2024 Jan 31:S0190-9622(24)00167.
    PubMed    
    
    
    
16. CHOI ME, Jung JM, Kim DH, Won CH, et al
    Baseline Serum Neutrophil-to-Lymphocyte Ratio in Acral Melanoma Compared to Non-Acral Melanoma and its Prognostic Significance.
    J Am Acad Dermatol. 2024 Jan 23:S0190-9622(24)00103.
    PubMed     Abstract available
    
    
    
17. TATE JA, Matsumoto A, Greif C, Lim J, et al
    Excision Margins for Melanoma in Situ on the Head and Neck - A Single-Center 10-year Retrospective Review of Treatment with Mohs Micrographic Surgery.
    J Am Acad Dermatol. 2024 Jan 20:S0190-9622(24)00102.
    PubMed     Abstract available
    
    
    
18. SHIFAI N, van Doorn R, Malvehy J, Sangers T, et al
    Can ChatGPT Vision Diagnose Melanoma? An Exploratory Diagnostic Accuracy Study.
    J Am Acad Dermatol. 2024 Jan 18:S0190-9622(24)00076.
    PubMed    
    
    
    
19. VIKSTROM S, Syriopoulou E, Andersson TM, Eriksson H, et al
    Loss in life expectancy in Patients with Stage II-III cutaneous melanoma in Sweden: a population-based cohort study.
    J Am Acad Dermatol. 2024 Jan 11:S0190-9622(24)00056.
    PubMed     Abstract available
    
    
    
20. TIMURKAYNAK O, Gonenli G
    Response to Young JN et al.'s "The utility of ChatGPT in generating patient-facing and clinical responses for melanoma".
    J Am Acad Dermatol. 2024 Jan 10:S0190-9622(24)00060.
    PubMed    
    
    
    
21. HEKLER A, Maron RC, Haggenmuller S, Schmitt M, et al
    Using Multiple Real-World Dermoscopic Photographs of One Lesion Improves Melanoma Classification via Deep Learning.
    J Am Acad Dermatol. 2024 Jan 8:S0190-9622(24)00048.
    PubMed    
    
    
    
22. NAVARRETE-DECHENT C, Jaimes N, Dusza SW, Liopyris K, et al
    Perifollicular linear projections: A dermatoscopic criterion for the diagnosis of lentigo maligna on the face.
    J Am Acad Dermatol. 2024;90:52-57.
    PubMed     Abstract available
    
    
    December 2023
23. BERK-KRAUSS J, Sharma M, Polsky D, Geller AC, et al
    Cutaneous Melanoma Incidence - Evidence of a Flattening Curve.
    J Am Acad Dermatol. 2023 Dec 10:S0190-9622(23)03288.
    PubMed    
    
    
    
24. HAGSTROM M, Dhillon S, Fumero-Velazquez M, Olivares S, et al
    A reappraisal of the epidemiology of Spitz neoplasms in the molecular era: A retrospective cohort study.
    J Am Acad Dermatol. 2023;89:1185-1191.
    PubMed     Abstract available
    
    
    
25. KOOPER-JOHNSON SB, Weber M, Eichtadt S, Nguyen BM, et al
    Limited commercialization of artificial intelligence technology in the diagnosis of pigmented lesions despite explosive growth in published programs.
    J Am Acad Dermatol. 2023;89:1246-1248.
    PubMed    
    
    
    
26. WAGNER NB, Knierim SM, Luttermann F, Metzler G, et al
    Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A
    J Am Acad Dermatol. 2023 Dec 1:S0190-9622(23)03250.
    PubMed     Abstract available
    
    
    
27. FERNANDEZ JM, Mata EM, Plampton K, Whitley MJ, et al
    Melanoma Characteristics and Overall Survival Predictors in American Indians and Alaska Natives: An Analysis of the National Cancer Database from 2004 to 2018.
    J Am Acad Dermatol. 2023 Dec 1:S0190-9622(23)03254.
    PubMed    
    
    
    November 2023
28. FERNANDEZ JM, Evans TD, Schissel M, Siller A Jr, et al
    Racial and ethnic differences in time to definitive surgery for melanoma: A retrospective study from the National Cancer Database.
    J Am Acad Dermatol. 2023 Nov 30:S0190-9622(23)03251.
    PubMed    
    
    
    
29. PAN CX, Liu M, Lau CB, Lau WC, et al
    Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors.
    J Am Acad Dermatol. 2023 Nov 29:S0190-9622(23)03239.
    PubMed    
    
    
    
30. HAWRYLUK EB, Moustafa D, Barry KK, Bahrani E, et al
    Risk Factors and Outcomes of Melanoma in Children and Adolescents: A Retrospective Multicenter Study.
    J Am Acad Dermatol. 2023 Nov 29:S0190-9622(23)03238.
    PubMed     Abstract available
    
    
    
31. FALDETTA C, Kaleci S, Chester J, Ruini C, et al
    Melanoma clinicopathological groups characterized and compared with dermoscopy and reflectance confocal microscopy.
    J Am Acad Dermatol. 2023 Nov 19:S0190-9622(23)03014.
    PubMed     Abstract available
    
    
    
32. MAGHFOUR J, Li P, Piontkowski A, Ozog D, et al
    Melanoma Incidence and Mortality: Exploring the Impact of Regional UV Radiation and Socioeconomic Status in the Context of Breslow Thickness.
    J Am Acad Dermatol. 2023 Nov 8:S0190-9622(23)03181.
    PubMed    
    
    
    
33. CLARK P, Howard H, Garrett E, Waters P, et al
    Health inequities in melanoma: A scoping review.
    J Am Acad Dermatol. 2023 Nov 2:S0190-9622(23)02892.
    PubMed    
    
    
    
34. KIM DY, Swetter SM, Huhmann L, Dizon MP, et al
    Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors among Veteran cutaneous melanoma patients.
    J Am Acad Dermatol. 2023 Nov 2:S0190-9622(23)03089.
    PubMed    
    
    
    
35. TOMAS-VELAZQUEZ A, Lopez-Gutierrez JC, Reyes-Mugica M, Salgado CM, et al
    Serum levels of S-100 protein are directly proportional to the size, number, thickness and degree of cellularity of congenital melanocytic nevi.
    J Am Acad Dermatol. 2023;89:1074-1077.
    PubMed    
    
    
    
36. AHMED F, Fisher MJ, Snyder KM, Smith K, et al
    Adverse cutaneous reactions associated with MEK inhibitor therapy in a pediatric population.
    J Am Acad Dermatol. 2023;89:1066-1068.
    PubMed    
    
    
    
37. KIM DY, Christopher Dee E, Cheng I, Hartman RI, et al
    Advanced melanoma presentation and disease-specific survival disparities among disaggregated Asian American, Native Hawaiian, and Pacific Islander populations.
    J Am Acad Dermatol. 2023 Nov 1:S0190-9622(23)03090.
    PubMed    
    
    
    October 2023
38. EVERDELL E, Shah H, Parisi R, Feustel PJ, et al
    Non-visibility of Suspicious Lesions by Patients Leads to Later Detection of Melanoma: A Retrospective Analysis.
    J Am Acad Dermatol. 2023 Oct 4:S0190-9622(23)02888.
    PubMed    
    
    
    
39. FERNANDEZ JM, Koblinski JE, Dahak S, Curiel-Lewandrowski C, et al
    Gender Differences in Pediatric and Adolescent Melanoma: A Retrospective Analysis of 4,645 Cases.
    J Am Acad Dermatol. 2023 Oct 4:S0190-9622(23)02866.
    PubMed     Abstract available
    
    
    
40. WAN G, Leung BW, DeSimone MS, Nguyen N, et al
    Development and Validation of Time-to-Event Models to Predict Metastatic Recurrence of Localized Cutaneous Melanoma.
    J Am Acad Dermatol. 2023 Oct 3:S0190-9622(23)02881.
    PubMed     Abstract available
    
    
    
41. YUMEEN S, Mirza FN, Mirza HN, Zogg CK, et al
    Malignant blue nevus: Characterization of US epidemiology and prognostic factors of a rare neoplasm with aggressive clinical course using the Surveillance, Epidemiology, and End Results Program database.
    J Am Acad Dermatol. 2023;89:843-846.
    PubMed    
    
    
    
42. KRENGEL S, Ott H, Waelchli R
    Recommendations for routine magnetic resonance imaging in children with congenital melanocytic nevi need revision Comment to Neale et al., J Am Acad Dermatol. 87(5):1060-1068.
    J Am Acad Dermatol. 2023;89:e153-e154.
    PubMed    
    
    
    September 2023
43. WEI AH, Fane LS, Tripathi R, Bordeaux JS, et al
    Differences in presentation of cutaneous melanoma among Asian American and Pacific Islander patients.
    J Am Acad Dermatol. 2023 Sep 26:S0190-9622(23)02868.
    PubMed    
    
    
    
44. WEI AH, Zheng DX, Cullison CR, Scott JF, et al
    Incidence and characteristics of acral lentiginous melanoma in Asian Americans and Pacific Islanders.
    J Am Acad Dermatol. 2023 Sep 19:S0190-9622(23)02828.
    PubMed    
    
    
    
45. TAN SX, Aung TN, Claeson M, Acs B, et al
    Automated scoring of tumour infiltrating lymphocytes informs risk of death from thin melanoma: a nested case-case study.
    J Am Acad Dermatol. 2023 Sep 18:S0190-9622(23)02833.
    PubMed    
    
    
    
46. NI Y, Watts CG, Scolyer RA, Madronio C, et al
    Prognosis for people with multiple primary melanomas compared with a single primary melanoma.
    J Am Acad Dermatol. 2023 Sep 13:S0190-9622(23)02693.
    PubMed    
    
    
    
47. WU Q, Pan J, Lin W, Zhao S, et al
    Clinicopathologic features, delayed diagnosis and survival in amelanotic acral melanoma: a comparative study with pigmented melanoma.
    J Am Acad Dermatol. 2023 Sep 8:S0190-9622(23)02677.
    PubMed    
    
    
    
48. LIN JY, Wang J, Mishra K, Osmani S, et al
    Non-Melanoma Skin Cancer in Skin of Color Solid Organ Transplant Recipients.
    J Am Acad Dermatol. 2023 Sep 7:S0190-9622(23)02678.
    PubMed    
    
    
    
49. GRANT-KELS JM
    JAAD Game Changers: Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment.
    J Am Acad Dermatol. 2023 Sep 7:S0190-9622(23)02674.
    PubMed    
    
    
    
50. JILANI S, D'Amiano NM, Thompson KG, Ellis J, et al
    Factors Affecting Follow-Up Adherence Following Mohs Micrographic Surgery in Patients with Non-Melanoma Skin Cancer: A Retrospective Chart Review.
    J Am Acad Dermatol. 2023 Sep 5:S0190-9622(23)02669.
    PubMed    
    
    
    
51. KIM U, Hoehn R, Schwartz GK, Cullen J, et al
    Evaluating disruptions in melanoma diagnosis resulting from the COVID-19 pandemic from a community-based perspective.
    J Am Acad Dermatol. 2023 Sep 2:S0190-9622(23)02659.
    PubMed    
    
    
    
52. COSTELLO CM, Dusza SW, Marghoob AA, Halpern AC, et al
    Melanoma Screening and Public Education for Minority Populations in the United States.
    J Am Acad Dermatol. 2023 Sep 2:S0190-9622(23)02663.
    PubMed    
    
    
    
53. ANVERY N, Kang B, Christensen RE, Dirr MA, et al
    Minimum thresholds deemed acceptable by patients and physicians for sensitivity and specificity of mobile skin cancer screening algorithms.
    J Am Acad Dermatol. 2023;89:595-597.
    PubMed    
    
    
    
54. CHOI S, Mulvaney P
    Evaluating the landscape of discount and patient assistance programs for topical sunscreen products in the United States.
    J Am Acad Dermatol. 2023;89:580-582.
    PubMed    
    
    
    August 2023
55. SORENSEN R
    Impact of scalp location on survival in head and neck melanoma: A retrospective cohort study.
    J Am Acad Dermatol. 2023 Aug 26:S0190-9622(23)02633.
    PubMed    
    
    
    
56. XIONG DD, Bordeaux J
    The impact of the COVID-19 pandemic in 2020 on the diagnosis, treatment, and outcomes of invasive cutaneous melanoma: a retrospective national cohort study.
    J Am Acad Dermatol. 2023 Aug 23:S0190-9622(23)02595.
    PubMed     Abstract available
    
    
    
57. BRODELL RT
    Primary dermal melanoma: A unique subtype of melanoma to be distinguished from cutaneous metastatic melanoma: A clinical, histologic, and gene expression-profiling study.
    J Am Acad Dermatol. 2023 Aug 16:S0190-9622(23)02515.
    PubMed    
    
    
    
58. ROSTER K, Rajeh A, Wu F, Wan G, et al
    Recurrence and Survival in Early-stage Acral Lentiginous Melanoma, A Retrospective Analysis.
    J Am Acad Dermatol. 2023 Aug 13:S0190-9622(23)02494.
    PubMed    
    
    
    
59. PAN CX, Lau WC, Kim DY, Lau CB, et al
    Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation.
    J Am Acad Dermatol. 2023 Aug 8:S0190-9622(23)02422.
    PubMed    
    
    
    
60. EL SHAROUNI MA, Lo SN, Scolyer RA, van Gils CH, et al
    Reply to: "Estrogen could also play a key role in the development of pediatric melanoma".
    J Am Acad Dermatol. 2023;89:e97-e98.
    PubMed    
    
    
    July 2023
61. AMARAL T, Pop OT, Chatziioannou E, Sinnberg T, et al
    EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.
    J Am Acad Dermatol. 2023 Jul 22:S0190-9622(23)02392.
    PubMed    
    
    
    
62. FREEMAN SC, Munoz EP, Latour E, Lim JY, et al
    External validation of the Melanoma Institute Australia Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database.
    J Am Acad Dermatol. 2023 Jul 14:S0190-9622(23)01350.
    PubMed     Abstract available
    
    
    
63. HOANG MP, Karpinski P, Zuniga-Castillo M, Foreman RK, et al
    Histologic Margin Status is a Predictor of Relapse in Lentigo Maligna Melanoma.
    J Am Acad Dermatol. 2023 Jul 14:S0190-9622(23)01349.
    PubMed     Abstract available
    
    
    
64. UGWU N, Cheraghlou S, Weiss J
    Primary Merkel Cell Carcinoma Is Associated with Increased, Extended Risk of Subsequent Melanoma and Non-Epithelial Skin Cancer.
    J Am Acad Dermatol. 2023 Jul 12:S0190-9622(23)01345.
    PubMed    
    
    
    
65. FERNANDEZ JM, Mata EM, Bubic BN, Kwan KR, et al
    Racial and ethnic differences in males with melanoma: A retrospective cohort study of 205,125 cases from the National Cancer Database.
    J Am Acad Dermatol. 2023 Jul 11:S0190-9622(23)01105.
    PubMed    
    
    
    
66. MUNOZ EP, Patel SP, Leachman SA, Yu NY, et al
    Minority Enrollment in Melanoma Clinical Trials.
    J Am Acad Dermatol. 2023 Jul 5:S0190-9622(23)01263.
    PubMed    
    
    
    
67. MEVES A, Todd A, Johnson EF
    Tumor width and calculated tumor area do not outperform Breslow thickness in predicting sentinel lymph node biopsy positivity.
    J Am Acad Dermatol. 2023;89:188-190.
    PubMed    
    
    
    
68. SMITH B, Smith JE, Demanelis K, Ferris LK, et al
    Changes in skin cancer screening rates in the United States from 2005 to 2015.
    J Am Acad Dermatol. 2023;89:142-145.
    PubMed    
    
    
    
69. MORGAN FC, Yehia L, McDonald C, Martinez-Agosto JA, et al
    Characterizing dermatologic findings among patients with PTEN hamartoma tumor syndrome: Results of a multicenter cohort study.
    J Am Acad Dermatol. 2023;89:90-98.
    PubMed     Abstract available
    
    
    June 2023
70. INGRASSIA JP, Adotama P, Stein JA, Polsky D, et al
    Re-examining melanoma secondary prevention and the role of skin self-examination.
    J Am Acad Dermatol. 2023 Jun 27:S0190-9622(23)01195.
    PubMed    
    
    
    
71. RYPKA KJ, Goldfarb N, Mansh M
    Response to the Feasibility of Kreher et al.'s "Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors".
    J Am Acad Dermatol. 2023 Jun 26:S0190-9622(23)01188.
    PubMed    
    
    
    
72. PAN CX, Nambudiri VE
    Response to: "Response to Pan et al.'s 'Non-melanoma skin cancer in patients with hereditary hemochromatosis: a case-control study.'".
    J Am Acad Dermatol. 2023 Jun 12:S0190-9622(23)01099.
    PubMed    
    
    
    
73. BARRY R, Murray G, Hazel K, Ryan J, et al
    Response to Pan et al.'s "Non-melanoma skin cancer in patients with hereditary hemochromatosis: a case-control study.".
    J Am Acad Dermatol. 2023 Jun 12:S0190-9622(23)01100.
    PubMed    
    
    
    
74. ABRANTES T, Robbins A, Kahn B, Yumeen S, et al
    Understanding melanoma in situ - lentigo maligna surgical treatment terminology and guideline adherence, a targeted review.
    J Am Acad Dermatol. 2023 Jun 10:S0190-9622(23)01084.
    PubMed     Abstract available
    
    
    
75. CHANG ALS, Zaba L, Kwong BY
    Immunotherapy for keratinocyte cancers. Part II: Identification and management of cutaneous side effects of immunotherapy treatments.
    J Am Acad Dermatol. 2023;88:1243-1255.
    PubMed     Abstract available
    
    
    
76. LEUNG BW, Wan G, Nguyen N, Rashdan H, et al
    Increased risk of cutaneous immune-related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort study.
    J Am Acad Dermatol. 2023;88:1265-1270.
    PubMed     Abstract available
    
    
    May 2023
77. LIM RK, Weinstock MA
    Racial disparities in diagnosis of invasive melanoma among veterans: A comparative analysis with the Surveillance, Epidemiology, and End Results Program.
    J Am Acad Dermatol. 2023 May 29:S0190-9622(23)00985.
    PubMed    
    
    
    
78. RAJEH A, Wan G, Roster K, Rashdan H, et al
    Underuse of sentinel lymph node biopsy for early-stage melanoma.
    J Am Acad Dermatol. 2023 May 25:S0190-9622(23)00975.
    PubMed    
    
    
    
79. KO MJ, Tsai WC, Tsai PH, Hsu LY, et al
    Ultraviolet B Phototherapy Does Not Increase the Risk of Skin Cancer Among Patients with Atopic Dermatitis: A Population-Based Retrospective Cohort Study.
    J Am Acad Dermatol. 2023 May 24:S0190-9622(23)00977.
    PubMed     Abstract available
    
    
    
80. HEERFORDT IM, Philipsen PA, Andersen JD, Langhans L, et al
    RNA analysis of tape strips to rule out melanoma in lesions clinically assessed as cutaneous malignant melanoma: A diagnostic study.
    J Am Acad Dermatol. 2023 May 22:S0190-9622(23)00971.
    PubMed     Abstract available
    
    
    
81. FANE LS, Wei AH, Tripathi R, Bordeaux JS, et al
    Asian American and Pacific Islander patients with melanoma have increased odds of treatment delays: a cross-sectional study.
    J Am Acad Dermatol. 2023 May 22:S0190-9622(23)00969.
    PubMed     Abstract available
    
    
    
82. KIM DY, Marchetti MA, Hartman RI
    Differences in thickness-specific incidence of cutaneous melanoma by county type in the United States, 2010-2019.
    J Am Acad Dermatol. 2023 May 17:S0190-9622(23)00905.
    PubMed    
    
    
    
83. YOUNG JN, O'Hagan R, Poplausky D, Levoska MA, et al
    The utility of ChatGPT in generating patient-facing and clinical responses for melanoma.
    J Am Acad Dermatol. 2023 May 17:S0190-9622(23)00908.
    PubMed    
    
    
    
84. ZHANG S, Tang K, Wan G, Nguyen N, et al
    Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study.
    J Am Acad Dermatol. 2023;88:1024-1032.
    PubMed     Abstract available
    
    
    
85. JOEL MZ, Tripathi R, Scott JF
    Predictors of receipt of sentinel lymph node biopsy in patients with malignant adnexal tumors of the skin.
    J Am Acad Dermatol. 2023;88:1179-1182.
    PubMed    
    
    
    
86. FELMINGHAM C, Pan Y, Kok Y, Kelly J, et al
    Improving skin cancer management with ARTificial intelligence: A pre-post intervention trial of an artificial intelligence system used as a diagnostic aid for skin cancer management in a real-world specialist dermatology setting.
    J Am Acad Dermatol. 2023;88:1138-1142.
    PubMed    
    
    
    
87. SHI K, Zhang B, Kong BY, Zhang Y, et al
    Distinct genomic features in a retrospective cohort of mucosal, acral, and vulvovaginal melanomas.
    J Am Acad Dermatol. 2023;88:1051-1059.
    PubMed     Abstract available
    
    
    
88. CAI ED, Swetter SM, Sarin KY
    Association of multiple primary melanomas with malignancy risk: A population-based analysis of entries from the Surveillance, Epidemiology, and End Results program database during 1973-2014.
    J Am Acad Dermatol. 2023;88:e211-e219.
    PubMed     Abstract available
    
    
    April 2023
89. AZOULAY L, St-Jean A, Dahl M, Quail J, et al
    Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multi-site population-based cohort study.
    J Am Acad Dermatol. 2023 Apr 25:S0190-9622(23)00735.
    PubMed     Abstract available
    
    
    
90. SHANNON AB, Karakousis GC
    The impact of the COVID-19 pandemic on new diagnoses of melanoma: a response to additional multi-institution and international reports.
    J Am Acad Dermatol. 2023 Apr 22:S0190-9622(23)00732.
    PubMed    
    
    
    
91. DRUMM C, Griffin C, Van Baarsel S, Quigley C, et al
    Response to Trepanowski et al.'s "Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study".
    J Am Acad Dermatol. 2023 Apr 21:S0190-9622(23)00733.
    PubMed    
    
    
    
92. CHOI ME, Yang HJ, Won CH, Chang SE, et al
    Differences in the Tumor Immunity-related Gene Expression Profile Between Acral Lentiginous and Non-acral Melanoma.
    J Am Acad Dermatol. 2023 Apr 19:S0190-9622(23)00712.
    PubMed    
    
    
    
93. FANE LS, Wei AH, Tripathi R, Bordeaux JS, et al
    Disparities between Asian groups in time to melanoma treatment: a cross-sectional study.
    J Am Acad Dermatol. 2023 Apr 11:S0190-9622(23)00589.
    PubMed    
    
    
    
94. HARVEY JA, Smith JF, Berry NA, Butterfield RJ, et al
    The influence of dermoscopy education over 14 years at a single institution: A retrospective cohort study.
    J Am Acad Dermatol. 2023;88:906-908.
    PubMed    
    
    
    March 2023
95. CRUM OM, Campbell EH, Reinhart JP, Proffer SL, et al
    Incidence Trends of Melanoma among Young Adults: An Epidemiologic Study in Olmsted County, Minnesota.
    J Am Acad Dermatol. 2023 Mar 29:S0190-9622(23)00518.
    PubMed    
    
    
    
96. MATA EM, Trinidad N, Blue E, Lobl M, et al
    Disparities in melanoma outcomes in urban versus rural settings: An analysis from the Nebraska Cancer Registry 2001-2016.
    J Am Acad Dermatol. 2023 Mar 20:S0190-9622(23)00450.
    PubMed    
    
    
    
97. MAGNATERRA E, Zuccaro B, Magliulo M, Venturi F, et al
    Estrogen could also play a key role in the development of pediatric melanoma.
    J Am Acad Dermatol. 2023 Mar 18:S0190-9622(23)00439.
    PubMed    
    
    
    
98. LIN EM, Lim RK, Lin S, Cho E, et al
    Disparities in Asian American Melanoma Diagnosis and Treatment from 1990-2014 -- Response to Zheng et al. "Poor melanoma outcomes and survival in Asian American and Pacific Islander patients".
    J Am Acad Dermatol. 2023 Mar 9:S0190-9622(23)00357.
    PubMed    
    
    
    
99. KIM DY, Behbahani S, Hartman RI
    Impact of COVID-19 pandemic on melanoma presentation by facility type and region in the United States.
    J Am Acad Dermatol. 2023 Mar 8:S0190-9622(23)00356.
    PubMed    
    
    
    
100. VERMARIEN-WANG J, Doeleman T, van Doorn R, Mooyaart AL, et al
     Ambiguous melanocytic lesions: A retrospective cohort study of incidence and outcome of melanocytic tumor of uncertain malignant potential (MELTUMP) and superficial atypical melanocytic proliferation of uncertain significance (SAMPUS) in the Netherlan
     J Am Acad Dermatol. 2023;88:602-608.
     PubMed     Abstract available
     
     
     
101. TARANTINO IS, Kwak YJ, Goldberg LH, Beroukhim K, et al
     Application of a taped gauze on the gloved hand in preparation for a pressure bandage after a Mohs micrographic surgery layer.
     J Am Acad Dermatol. 2023;88:e125-e126.
     PubMed    
     
     
     
102. LEE K
     JAAD Game Changers *: The association of indoor tanning and melanoma in adults: Systematic review and meta-analysis.
     J Am Acad Dermatol. 2023;88:749.
     PubMed    
     
     
     February 2023
103. IQBAL A, Bell MC, Merkel EA, Somani AK, et al
     The effect of tumor mitotic rate on melanoma-specific survival: A SEER population-based study of 54,598 cases.
     J Am Acad Dermatol. 2023 Feb 23:S0190-9622(23)00274.
     PubMed    
     
     
     
104. NGUYEN N, Wan G, Ugwu-Dike P, Alexander NA, et al
     Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy.
     J Am Acad Dermatol. 2023 Feb 22:S0190-9622(23)00204.
     PubMed     Abstract available
     
     
     
105. DESSINIOTI C, Plaka M, Kypreou K, Stergiopoulou A, et al
     A retrospective study of small-diameter invasive melanomas: metastasis at diagnosis and 9-year follow-up.
     J Am Acad Dermatol. 2023 Feb 21:S0190-9622(23)00267.
     PubMed    
     
     
     
106. STEPHENS MR, Asdourian MS, Jacoby TV, Shah N, et al
     Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma.
     J Am Acad Dermatol. 2023 Feb 15:S0190-9622(23)00193.
     PubMed    
     
     
     
107. WILSON BN, Shah R, Musthaq S, Vaidya T, et al
     Development of patient decision aids for the treatment of lentigo maligna and low-risk basal cell carcinoma.
     J Am Acad Dermatol. 2023;88:440-442.
     PubMed    
     
     
     
108. NAVARRETE-DECHENT C, Cordova M, Aleissa S, Liopyris K, et al
     Lentigo maligna melanoma mapping using reflectance confocal microscopy correlates with staged excision: A prospective study.
     J Am Acad Dermatol. 2023;88:371-379.
     PubMed     Abstract available
     
     
     
109. LEE K
     JAAD Game Changers: Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp.
     J Am Acad Dermatol. 2023;88:517.
     PubMed    
     
     
     January 2023
110. YOUNG JN, Nguyen TA, Freeman SC, Hill E, et al
     Permanent section margin concordance after Mohs micrographic surgery with immunohistochemistry for invasive melanoma and melanoma in situ: a retrospective dual-center analysis.
     J Am Acad Dermatol. 2023 Jan 28:S0190-9622(23)00141.
     PubMed     Abstract available
     
     
     
111. STULL CM, Nugent ST, Raj LK, Sobanko JF, et al
     Frequency and reliability of histologic subtype classification in invasive and in situ melanoma treated with Mohs micrographic surgery.
     J Am Acad Dermatol. 2023 Jan 17:S0190-9622(23)00082.
     PubMed    
     
     
     
112. BEAL BT, Udkoff J, Aizman L, Etzkorn J, et al
     Outcomes of invasive melanoma of the head and neck treated with Mohs Micrographic Surgery - a multicenter study.
     J Am Acad Dermatol. 2023 Jan 12:S0190-9622(23)00062.
     PubMed     Abstract available
     
     
     
113. OH BH, Lee S, Park JW, Lee JY, et al
     Risk of recurrence of nail unit melanoma after functional surgery versus amputation.
     J Am Acad Dermatol. 2023 Jan 12:S0190-9622(23)00063.
     PubMed     Abstract available
     
     
     
114. WOJCIK KY, Hawkins M, Anderson-Mellies A, Hall E, et al
     Melanoma Survival by Age Group: Population-Based Disparities for Adolescent and Young Adult Patients by Stage, Tumor Thickness, and Insurance Type.
     J Am Acad Dermatol. 2023 Jan 4:S0190-9622(23)00003.
     PubMed     Abstract available
     
     
     
115. SPACCARELLI N, Drozdowski R, Peters MS, Grant-Kels JM, et al
     Dysplastic nevus part II: Dysplastic nevi: Molecular/genetic profiles and management.
     J Am Acad Dermatol. 2023;88:13-20.
     PubMed     Abstract available
     
     
     
116. DROZDOWSKI R, Spaccarelli N, Peters MS, Grant-Kels JM, et al
     Dysplastic nevus part I: Historical perspective, classification, and epidemiology.
     J Am Acad Dermatol. 2023;88:1-10.
     PubMed     Abstract available
     
     
     
117. FARIES MB, Cochran AJ, Thompson JF
     Re: "Time to reconsider the role of sentinel lymph node biopsy in melanoma".
     J Am Acad Dermatol. 2023;88:e25-e26.
     PubMed    
     
     
     
118. BEAULIEU D, Tsao H, Michaud DS, Okhovat JP, et al
     Factors associated with suspected nonmelanoma skin cancers, dysplastic nevus, and cutaneous melanoma among first-time SpotMe screening program participants during 2009-2010.
     J Am Acad Dermatol. 2023;88:60-70.
     PubMed     Abstract available
     
     
     December 2022
119. VALEK SA, Rousseau MA, Nelson KC, Kannler C, et al
     Melanoma risk among career firefighters: A systematic review of case-control studies.
     J Am Acad Dermatol. 2022 Dec 30:S0190-9622(22)03320.
     PubMed    
     
     
     
120. ROUSSET P, Dalle S, Mortier L, Dereure O, et al
     Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort.
     J Am Acad Dermatol. 2022 Dec 19:S0190-9622(22)03142.
     PubMed     Abstract available
     
     
     
121. HUERTA T, Swetter SM, Nehal KS, Coit DG, et al
     Current evidence does not support Mohs micrographic surgery or staged excision as equivalent to wide excision for primary cutaneous melanoma.
     J Am Acad Dermatol. 2022 Dec 16:S0190-9622(22)03308.
     PubMed    
     
     
     
122. PEDERSEN EA, Harms PW, Zhao L, Andea AA, et al
     Polypoid melanoma is associated with aggressive histopathological characteristics and poor clinical prognosis: A retrospective cohort study.
     J Am Acad Dermatol. 2022 Dec 10:S0190-9622(22)03181.
     PubMed    
     
     
     
123. EL SHAROUNI MA, Rawson RV, Potter AJ, Paver EC, et al
     Melanomas in children and adolescents: clinicopathologic features and survival outcomes.
     J Am Acad Dermatol. 2022 Dec 9:S0190-9622(22)03176.
     PubMed     Abstract available
     
     
     November 2022
124. KREHER MA, Noland MMB, Konda S, Longo MI, et al
     Risk of melanoma and nonmelanoma skin cancer with immunosuppressants Part I: Calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids.
     J Am Acad Dermatol. 2022 Nov 29:S0190-9622(22)03145.
     PubMed     Abstract available
     
     
     
125. KREHER MA, Konda S, Noland MMB, Longo MI, et al
     Risk of melanoma and nonmelanoma skin cancer with immunosuppressants Part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors.
     J Am Acad Dermatol. 2022 Nov 29:S0190-9622(22)03146.
     PubMed     Abstract available
     
     
     
126. SHARON CE, Straker RJ 3rd, Gimotty PA, Chu EY, et al
     Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB/C melanoma: a population-based analysis.
     J Am Acad Dermatol. 2022 Nov 25:S0190-9622(22)03133.
     PubMed     Abstract available
     
     
     
127. KNACKSTEDT T
     Differences in Sentinel Lymph Node Biopsy Utilization in Eligible Melanoma Patients Treated with Mohs Micrographic Surgery or Wide Local Excision: A population-based logistic regression model and survival analysis.
     J Am Acad Dermatol. 2022 Nov 8. pii: S0190-9622(22)02988.
     PubMed     Abstract available
     
     
     
128. VAN MOLLE P, Brochez L, Verbelen T, De Boom C, et al
     The value of measuring uncertainty in neural networks in dermoscopy.
     J Am Acad Dermatol. 2022;87:1191-1193.
     PubMed    
     
     
     
129. SEIVERLING EV, Stevens K, Dorr G, Prentiss MA, et al
     Impact of multimodal dermatoscopy training on skin biopsies by primary care providers.
     J Am Acad Dermatol. 2022;87:1119-1121.
     PubMed    
     
     
     October 2022
130. ROTH A, Boutko A, Lampley N 3rd, Olivares S, et al
     Indoor tanning is associated with an increased risk for multiple primary melanomas: A case-control study.
     J Am Acad Dermatol. 2022 Oct 30. pii: S0190-9622(22)02781.
     PubMed    
     
     
     
131. RIQUELME-MC LOUGHLIN C, Sandoval-Clavijo A, de Tord MB, Boada A, et al
     Prognostic role of microsatellites in melanoma and implications in the AJCC classification system: a cohort study.
     J Am Acad Dermatol. 2022 Oct 17. pii: S0190-9622(22)02898.
     PubMed     Abstract available
     
     
     
132. FERNANDEZ JM, Dahak S, Wysong A, Whitley MJ, et al
     Differences Between Asian Americans and Pacific Islanders with Cutaneous Melanoma: A Retrospective Cohort Analysis of 1,339 Cases.
     J Am Acad Dermatol. 2022 Oct 13. pii: S0190-9622(22)02887.
     PubMed    
     
     
     
133. FERNANDEZ JM, Mata EM, Behbahani S, Kwan KR, et al
     Survival of Hispanic Patients with Cutaneous Melanoma: A Retrospective Cohort Analysis of 6,016 Cases from the National Cancer Database.
     J Am Acad Dermatol. 2022 Oct 10. pii: S0190-9622(22)02806.
     PubMed    
     
     
     
134. ROSENTHAL A, Reddy S, Cooper R, Chung J, et al
     Disparities in Melanoma-Specific Mortality by Race/Ethnicity, Socioeconomic Status, and Healthcare Systems.
     J Am Acad Dermatol. 2022 Oct 10. pii: S0190-9622(22)02800.
     PubMed     Abstract available
     
     
     
135. LEE DK, Chang MJ, Desai AD, Lipner SR, et al
     Clinical and dermoscopic findings of benign longitudinal melanonychia due to melanocytic activation differ by skin type and predict likelihood of nail matrix biopsy.
     J Am Acad Dermatol. 2022;87:792-799.
     PubMed     Abstract available
     
     
     
136. JAIN M, Autuori I, Everett N, Harris U, et al
     Minimally invasive microbiopsy for genetic profiling of melanocytic lesions: A case series.
     J Am Acad Dermatol. 2022;87:903-904.
     PubMed    
     
     
     
137. DELLATORRE G, Gadens GA, Polo Silveira L, Kose K, et al
     Video-based wide area digital dermoscopy.
     J Am Acad Dermatol. 2022;87:e125-e126.
     PubMed    
     
     
     September 2022
138. SHANNON AB, Sharon CE, Straker RJ 3rd, Carr MJ, et al
     Sentinel Lymph Node Biopsy in Patients with T1a Cutaneous Malignant Melanoma: A Multi-Center Cohort Study.
     J Am Acad Dermatol. 2022 Sep 29. pii: S0190-9622(22)02783.
     PubMed     Abstract available
     
     
     
139. 
     The association between COVID-19 lockdowns and melanoma diagnosis and thickness: A multicenter retrospective study from Europe.
     J Am Acad Dermatol. 2022 Sep 24. pii: S0190-9622(22)02780.
     PubMed    
     
     
     
140. WEI X, Chen Y, Yao H, Wu D, et al
     Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis.
     J Am Acad Dermatol. 2022 Sep 5. pii: S0190-9622(22)02627.
     PubMed     Abstract available
     
     
     
141. KIM CG, Kim M, Hwang J, Kim ST, et al
     First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanoma.
     J Am Acad Dermatol. 2022 Sep 3. pii: S0190-9622(22)02443.
     PubMed     Abstract available
     
     
     
142. PHAM F, Boespflug A, Duru G, Phan A, et al
     Dermatoscopic and clinical features of congenital or congenital-type nail matrix nevi: A multicenter prospective cohort study by the International Dermoscopy Society.
     J Am Acad Dermatol. 2022;87:551-558.
     PubMed     Abstract available
     
     
     
143. PHAM JP, Star P, Phan K, Loh Y, et al
     BRAF inhibition and the spectrum of granulomatous reactions.
     J Am Acad Dermatol. 2022;87:605-613.
     PubMed     Abstract available
     
     
     August 2022
144. FALOTICO JM, Postow MA, Lipner SR
     Standardized guidelines for acral and nail unit melanoma treatment are lacking.
     J Am Acad Dermatol. 2022 Aug 18. pii: S0190-9622(22)02548.
     PubMed    
     
     
     
145. CHERAGHLOU S, Doudican NA, Criscito MC, Stevenson ML, et al
     Assessing rates of compliance with national guidelines regarding sentinel lymph node biopsy for invasive melanomas treated with Mohs micrographic surgery.
     J Am Acad Dermatol. 2022 Aug 17. pii: S0190-9622(22)02544.
     PubMed    
     
     
     
146. KOLLA AM, Seixas A, Adotama P, Foster V, et al
     A Health Equity Framework to Address Racial and Ethnic Disparities in Melanoma.
     J Am Acad Dermatol. 2022 Aug 12. pii: S0190-9622(22)02526.
     PubMed    
     
     
     
147. RAN NA, Nugent ST, Veerabagu S, Chu EY, et al
     Desmoplastic melanoma treated with wide local excision or Mohs micrographic surgery - rates of positive margins, local recurrence, and repeat surgeries.
     J Am Acad Dermatol. 2022 Aug 10. pii: S0190-9622(22)02450.
     PubMed    
     
     
     
148. FERNANDEZ JM, Bubic BN, Dahak S, Mata EM, et al
     Racial and Ethnic Differences in Tumor Characteristics and Overall Survival of Women with Melanoma: A National Cancer Database Retrospective Cohort Study.
     J Am Acad Dermatol. 2022 Aug 3. pii: S0190-9622(22)02413.
     PubMed    
     
     
     
149. MARCAILLOU M, Dion J, Baroudjian B, Ezrine E, et al
     Sample CME manuscript submission: Response to the article by Pham et al entitled "Review BRAF inhibition and the spectrum of granulomatous reactions".
     J Am Acad Dermatol. 2022;87:e85-e88.
     PubMed    
     
     
     
150. LEE JS, Kim S, Kim DH, Lee JW, et al
     Clinical features and natural course of pediatric longitudinal melanonychia: A retrospective cohort study in Korea.
     J Am Acad Dermatol. 2022;87:366-372.
     PubMed     Abstract available
     
     
     
151. PEREZ M, Abisaad JA, Rojas KD, Marchetti MA, et al
     Skin cancer: Primary, secondary, and tertiary prevention. Part I.
     J Am Acad Dermatol. 2022;87:255-268.
     PubMed     Abstract available
     
     
     July 2022
152. PAN CX, Yang K, Lau CB, Zhou G, et al
     Non-melanoma skin cancer in patients with hereditary hemochromatosis: a case-control study.
     J Am Acad Dermatol. 2022 Jul 21. pii: S0190-9622(22)02400.
     PubMed    
     
     
     
153. JARELL A, Gastman BR, Dillon LD, Hsueh EC, et al
     Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test.
     J Am Acad Dermatol. 2022 Jul 7. pii: S0190-9622(22)02253.
     PubMed     Abstract available
     
     
     
154. MULLIGAN KM, Cullison CR, Zheng DX, Rothermel LD, et al
     Mucosal melanoma and organ-specific metastasis: Differences in survival outcomes between tumor primary sites.
     J Am Acad Dermatol. 2022 Jul 5. pii: S0190-9622(22)02248.
     PubMed    
     
     
     
155. XIONG DD, Barriera-Silvestrini P, Knackstedt TJ
     Delays in surgical treatment of melanoma are associated with worsened overall and melanoma-specific mortality: a population-based analysis.
     J Am Acad Dermatol. 2022 Jul 1. pii: S0190-9622(22)02239.
     PubMed     Abstract available
     
     
     June 2022
156. TREPANOWSKI N, Chang MS, Zhou G, Ahmad M, et al
     Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study.
     J Am Acad Dermatol. 2022 Jun 20. pii: S0190-9622(22)01023.
     PubMed    
     
     
     
157. CHOI ME, Won CH, Chang SE, Lee MW, et al
     Clinical and Prognostic Influence of Tumor Diameter in Acral Lentiginous Melanoma.
     J Am Acad Dermatol. 2022 Jun 17. pii: S0190-9622(22)01019.
     PubMed    
     
     
     
158. ELSTON DM
     Letter from the editor: Delays in Melanoma Diagnosis.
     J Am Acad Dermatol. 2022 Jun 16. pii: S0190-9622(22)01011.
     PubMed    
     
     
     
159. KUMAR AB, Peters MS, Jakub JW, Harmsen W, et al
     "Primary cutaneous melanoma features predict development of intransit metastases/satellite lesions: Mayo Clinic experience 2010-2014".
     J Am Acad Dermatol. 2022 Jun 13. pii: S0190-9622(22)00994.
     PubMed    
     
     
     
160. BLUMENTHAL LY, Hu JC
     Response to "Comment on 'Racial/Ethnic disparities in non-melanoma skin cancer based on Mohs micrographic surgery defect size, a multicenter retrospective study'".
     J Am Acad Dermatol. 2022 Jun 2. pii: S0190-9622(22)00902.
     PubMed    
     
     
     May 2022
161. KURN HA, Abercrombie M, Tzellos T, Dellavalle RP, et al
     From the Cochrane Library: Interventions for Melanoma in Situ, Including Lentigo Maligna.
     J Am Acad Dermatol. 2022 May 28. pii: S0190-9622(22)00889.
     PubMed    
     
     
     
162. SCHARF C, Brancaccio G, Di Stefani A, Fargnoli MC, et al
     THE ASSOCIATION BETWEEN LOCKDOWNS DURING THE COVID-19 PANDEMIC AND MELANOMA DIAGNOSIS: A MULTICENTER RETROSPECTIVE STUDY FROM EUROPE.
     J Am Acad Dermatol. 2022 May 16. pii: S0190-9622(22)00812.
     PubMed    
     
     
     
163. LUU YT, Goldstein AM, Sargen MR
     Variation in second cancer risk by melanoma subtype among survivors.
     J Am Acad Dermatol. 2022 May 16. pii: S0190-9622(22)00816.
     PubMed    
     
     
     
164. SHAIKH SS, Yang X, Fortman DD, Wang H, et al
     A Retrospective Analysis of the Impact of the COVID-19 Pandemic on Staging at Presentation of Patients with Invasive Melanoma.
     J Am Acad Dermatol. 2022 May 9. pii: S0190-9622(22)00798.
     PubMed    
     
     
     
165. BRUNSGAARD E, Wu YP, Grossman D
     Melanoma in Skin of Color: Part I. Epidemiology and clinical presentation.
     J Am Acad Dermatol. 2022 May 6. pii: S0190-9622(22)00783.
     PubMed     Abstract available
     
     
     
166. BRUNSGAARD E, Jensen J, Grossman D
     Melanoma in Skin of Color: Part II. Racial disparities, role of UV, and interventions for earlier detection.
     J Am Acad Dermatol. 2022 May 6. pii: S0190-9622(22)00784.
     PubMed     Abstract available
     
     
     
167. SARVER MM, Rames JD, Beasley GM, Gao J, et al
     Survival and Tumor Characteristics of Patients Presenting with Single Primary vs. Second Primary Melanoma Lesions.
     J Am Acad Dermatol. 2022 May 4. pii: S0190-9622(22)00715.
     PubMed     Abstract available
     
     
     
168. CONDORELLI AG, Farnetani F, Ciardo S, Chester J, et al
     Dynamic dermoscopic and reflectance confocal microscopic changes of melanocytic lesions excised during follow up.
     J Am Acad Dermatol. 2022;86:1049-1057.
     PubMed     Abstract available
     
     
     
169. SOENEN A, Vourc'h M, Khammari A, Nguyen JM, et al
     Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management.
     J Am Acad Dermatol. 2022;86:1042-1048.
     PubMed     Abstract available
     
     
     April 2022
170. MORAES AFA, Blumetti TCMP, Pinto C, Bertoli E, et al
     Melanoma with peripheral globules: clinical and dermoscopic features.
     J Am Acad Dermatol. 2022 Apr 26. pii: S0190-9622(22)00697.
     PubMed     Abstract available
     
     
     
171. STRAKER RJ 3RD, Sharon CE, Chu EY, Miura JT, et al
     Sentinel lymph node biopsy in patients with clinical stage IIB/C cutaneous melanoma: A national cohort study.
     J Am Acad Dermatol. 2022 Apr 22. pii: S0190-9622(22)00681.
     PubMed     Abstract available
     
     
     March 2022
172. HOBAYAN CGP, Grant-Kels JM, Korman AM
     The ethics of dismissing a melanoma patient who repeatedly no-shows.
     J Am Acad Dermatol. 2022 Mar 19. pii: S0190-9622(22)00504.
     PubMed    
     
     
     
173. CHANG MS, La J, Trepanowski N, Cheng D, et al
     Increased relative proportions of advanced melanoma among Veterans: a comparative analysis with the SEER registry.
     J Am Acad Dermatol. 2022 Mar 9. pii: S0190-9622(22)00392.
     PubMed     Abstract available
     
     
     
174. WONGVIBULSIN S, Pahalyants V, Kalinich M, Murphy W, et al
     Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.
     J Am Acad Dermatol. 2022;86:563-572.
     PubMed     Abstract available
     
     
     February 2022
175. ASDOURIAN MS, Otto TS, Jacoby TV, Shah N, et al
     Association between serum LDH and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.
     J Am Acad Dermatol. 2022 Feb 19. pii: S0190-9622(22)00335.
     PubMed    
     
     
     
176. EL SHAROUNI MA, Rawson RV, Sigurdsson V, Witkamp AJ, et al
     The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultra-thick melanomas (>/=15mm in thickness).
     J Am Acad Dermatol. 2022 Feb 1. pii: S0190-9622(22)00174.
     PubMed     Abstract available
     
     
     January 2022
177. PRASAD S, Black S, Chen HW, Joseph A, et al
     Beliefs and barriers to care of primary care practitioners towards melanoma screening and education in rural Texas.
     J Am Acad Dermatol. 2022 Jan 22. pii: S0190-9622(22)00091.
     PubMed    
     
     
     
178. MUZUMDAR S, Wu R, Rothe MJ, Grant-Kels JM, et al
     Reflectance confocal microscopy decreases the cost of skin lesion diagnosis: A single institution retrospective chart review.
     J Am Acad Dermatol. 2022;86:209-211.
     PubMed    
     
     
     December 2021
179. SKUDALSKI L, Waldman R, Kerr PE, Grant-Kels JM, et al
     Melanoma: How and When to Consider Clinical Diagnostic Technologies.
     J Am Acad Dermatol. 2021 Dec 13. pii: S0190-9622(21)02971.
     PubMed     Abstract available
     
     
     
180. SKUDALSKI L, Waldman R, Kerr PE, Grant-Kels JM, et al
     Melanoma: An Update on Systemic Therapies.
     J Am Acad Dermatol. 2021 Dec 13. pii: S0190-9622(21)02970.
     PubMed     Abstract available
     
     
     
181. GOLDSMITH SM
     Comment on "Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas".
     J Am Acad Dermatol. 2021;85:e361.
     PubMed    
     
     
     
182. VASICEK B, Erickson T, Lake E
     Comment on "Descriptive survival study of nail melanoma patients treated with functional surgery versus distal amputation".
     J Am Acad Dermatol. 2021;85:e351.
     PubMed    
     
     
     
183. MONTAGNER S
     Reply to: "Comment on 'Descriptive survival study of nail melanoma patients treated with functional surgery versus distal amputation'".
     J Am Acad Dermatol. 2021;85:e353.
     PubMed    
     
     
     
184. OKHOVAT JP, Davine JA, Hawryluk EB, Geller AC, et al
     Educational brochure impact on postscreening practices of American Academy of Dermatology skin cancer screening participants.
     J Am Acad Dermatol. 2021;85:1616-1617.
     PubMed    
     
     
     
185. ZAKHEM GA, Fakhoury JW, Motosko CC, Ho RS, et al
     Characterizing the role of dermatologists in developing artificial intelligence for assessment of skin cancer.
     J Am Acad Dermatol. 2021;85:1544-1556.
     PubMed     Abstract available
     
     
     November 2021
186. KURN HA, Sivesind TE, Dellavalle RP
     From the Cochrane Library: Screening for Reducing Morbidity and Mortality in Malignant Melanoma.
     J Am Acad Dermatol. 2021 Nov 25. pii: S0190-9622(21)02909.
     PubMed    
     
     
     
187. RAVAL NS, Hodges WT, Ugwu-Dike PO, Godoy F, et al
     Racial and socioeconomic differences in acral lentiginous melanoma outcomes: a SEER analysis.
     J Am Acad Dermatol. 2021 Nov 20. pii: S0190-9622(21)02856.
     PubMed    
     
     
     
188. THORPE RB, Covington KR, Caruso HG, Quick AP, et al
     Development and validation of a nomogram incorporating gene expression profiling and clinical factors for accurate prediction of metastasis in patients with cutaneous melanoma following Mohs micrographic surgery.
     J Am Acad Dermatol. 2021 Nov 19. pii: S0190-9622(21)02854.
     PubMed     Abstract available
     
     
     
189. KANTOR J
     This Month in JAAD International: February 2022: Vitiligo in melanoma patients treated with anti-PD-1 therapies and improved survival.
     J Am Acad Dermatol. 2021 Nov 6. pii: S0190-9622(21)02749.
     PubMed    
     
     
     
190. SOENEN A, Vourc'h M, Dreno B, Chiaverini C, et al
     Diagnosis of congenital pigmented macules in infants with reflectance confocal microscopy and machine learning.
     J Am Acad Dermatol. 2021;85:1308-1309.
     PubMed    
     
     
     
191. MAZMUDAR RS, Fazio J, Garland K, Tripathi R, et al
     Predictors of patient-initiated communication after Mohs micrographic surgery: A multi-institutional prospective cohort study.
     J Am Acad Dermatol. 2021;85:1290-1293.
     PubMed    
     
     
     
192. GOMEZ-MARTIN I, Collgros H, Ferguson PM, Barreiro A, et al
     Diagnostic accuracy of pigmented labial macules by in vivo reflectance confocal microscopy and correlation among techniques.
     J Am Acad Dermatol. 2021;85:1151-1160.
     PubMed     Abstract available
     
     
     
193. TRIPATHI R, Bordeaux JS, Nijhawan RI
     Utilization of palliative therapy for metastatic melanoma in the United States.
     J Am Acad Dermatol. 2021;85:1342-1345.
     PubMed    
     
     
     
194. CHANG MS, Huang L, Mostaghimi A, Hartman RI, et al
     Lifetime history of total body skin examinations in patients with disabilities: Examining for differences in skin cancer screening.
     J Am Acad Dermatol. 2021;85:1326-1328.
     PubMed    
     
     
     October 2021
195. FARAH M, Chung HJ
     Diagnostic Utility of PRAME Immunohistochemistry in the Evaluation of Melanomas with a Co-existent Nevoid Melanocytic Population: A Single Center Retrospective Cohort Study.
     J Am Acad Dermatol. 2021 Oct 28. pii: S0190-9622(21)02714.
     PubMed    
     
     
     
196. IPENBURG NA, El Sharouni MA, van Doorn R, van Diest PJ, et al
     Lack of association between CDKN2A germline mutations and survival in melanoma patients: a retrospective cohort study.
     J Am Acad Dermatol. 2021 Oct 22. pii: S0190-9622(21)02677.
     PubMed    
     
     
     
197. LIN JQ, Li SQ, Li S, Kiamanesh EF, et al
     A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients.
     J Am Acad Dermatol. 2021 Oct 11. pii: S0190-9622(21)02632.
     PubMed     Abstract available
     
     
     
198. LITCHMAN GH, Teplitz RW, Marson JW, Rigel DS, et al
     Impact of electrical impedance spectroscopy on dermatologists' number needed to biopsy metric and biopsy decisions for pigmented skin lesions.
     J Am Acad Dermatol. 2021;85:976-979.
     PubMed    
     
     
     September 2021
199. GAGHAN LJ, Bui H, Lipner SR, Jellinek NJ, et al
     Evaluation of a community education tool for detection of nail melanoma by nail salon technicians.
     J Am Acad Dermatol. 2021 Sep 21. pii: S0190-9622(21)02503.
     PubMed    
     
     
     
200. BLUMENTHAL LY, Arzeno J, Syder N, Rabi S, et al
     Disparities in non-melanoma skin cancer in Hispanic/Latino patients based on Mohs micrographic surgery defect size, a multicenter retrospective study.
     J Am Acad Dermatol. 2021 Sep 4. pii: S0190-9622(21)02423.
     PubMed     Abstract available
     
     
     
201. LALLAS A, Kyrgidis A, Manoli SM, Papageorgiou C, et al
     Delayed skin cancer diagnosis in 2020 because of the COVID-19-related restrictions: Data from an institutional registry.
     J Am Acad Dermatol. 2021;85:721-723.
     PubMed    
     
     
     August 2021
202. MCFEELY O, Hollywood A, Stanciu M, O'Connell M, et al
     Comment on "The Impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: a single institution experience".
     J Am Acad Dermatol. 2021 Aug 28. pii: S0190-9622(21)02383.
     PubMed    
     
     
     
203. STRAKER RJ 3RD, Kelly N, Sharon CE, Shannon AB, et al
     Local recurrence in patients undergoing wide excision and sentinel lymph node biopsy for cutaneous malignant melanoma: A single-center, retrospective cohort analysis.
     J Am Acad Dermatol. 2021 Aug 12. pii: S0190-9622(21)02299.
     PubMed    
     
     
     
204. YAN BY, Barilla S, Strunk A, Garg A, et al
     Survival Differences in Acral Lentiginous Melanoma According to Socioeconomic Status and Race.
     J Am Acad Dermatol. 2021 Aug 4. pii: S0190-9622(21)02210.
     PubMed     Abstract available
     
     
     
205. PARISI R, Huppertz J, Potolski A, Tracey V, et al
     Distance to Diagnosing Dermatology Provider as a Predictor of Multiple Melanoma Diagnoses.
     J Am Acad Dermatol. 2021 Aug 3. pii: S0190-9622(21)02214.
     PubMed    
     
     
     
206. KANTOR J
     August 2021: On the epistemology of Breslow thickness and histopathologic melanoma subtype.
     J Am Acad Dermatol. 2021;85:318.
     PubMed    
     
     
     
207. WANG TS, Griffiths CC, Roman EM
     Should topical imiquimod be used for positive margins in lentigo maligna?
     J Am Acad Dermatol. 2021;85:521-522.
     PubMed    
     
     
     July 2021
208. GAUDY-MARQUESTE C, Macagno N, Loundou A, Pellegrino E, et al
     Molecular characterization of fast-growing melanomas.
     J Am Acad Dermatol. 2021 Jul 16. pii: S0190-9622(21)02101.
     PubMed     Abstract available
     
     
     
209. BUI AN, Bougrine A, Buchbinder EI, Giobbie-Hurder A, et al
     Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: a retrospective cohort study.
     J Am Acad Dermatol. 2021 Jul 9. pii: S0190-9622(21)02087.
     PubMed    
     
     
     
210. STRAKER RJ 3RD, Thaler AS, Shannon AB, Miura JT, et al
     Acral lentiginous melanoma in the era of immune checkpoint blockade and targeted therapy: A National Cancer Database analysis.
     J Am Acad Dermatol. 2021 Jul 9. pii: S0190-9622(21)02095.
     PubMed    
     
     
     June 2021
211. YOO H, Kim H, Kwon ST, Jo SJ, et al
     Tumor invasion in the hyponychium is associated with distant metastasis and poor prognosis in subungual melanoma: A histological landscape of 44 cases.
     J Am Acad Dermatol. 2021 Jun 18. pii: S0190-9622(21)01989.
     PubMed     Abstract available
     
     
     
212. CARLET C, Dalle S, Leccia MT, Mortier L, et al
     Late-onset adverse events under anti-PD1 therapy in melanoma patients: an observational study from MELBASE, a nationwide prospective cohort.
     J Am Acad Dermatol. 2021 Jun 18. pii: S0190-9622(21)01991.
     PubMed     Abstract available
     
     
     
213. FIGUEROA-SILVA O, Suarez-Penaranda JM, Balboa-Barreiro V, Rojas SA, et al
     Volume tumor impact on melanoma survival assessed through Breslow density.
     J Am Acad Dermatol. 2021 Jun 8. pii: S0190-9622(21)01107.
     PubMed    
     
     
     
214. MUZUMDAR S, Lin G, Kerr P, Grant-Kels JM, et al
     Is Melanoma Overdiagnosed? A Review of the Evidence.
     J Am Acad Dermatol. 2021 Jun 8. pii: S0190-9622(21)01110.
     PubMed     Abstract available
     
     
     
215. BEAULIEU D, Gao DX, Swetter SM, Hawryluk EB, et al
     Association between income and suspected non-melanoma and melanoma skin cancers among participants of the American Academy of Dermatology's SPOT Skin Cancer(R) screening program - A cross-sectional analysis.
     J Am Acad Dermatol. 2021 Jun 2. pii: S0190-9622(21)01044.
     PubMed    
     
     
     
216. VAIDYA TS, Bander TS, Musthaq S, Lampley N 3rd, et al
     Validation of a patient decision aid for the treatment of lentigo maligna.
     J Am Acad Dermatol. 2021;84:1751-1753.
     PubMed    
     
     
     
217. HANLON KL, Correa-Selm LM, Grichnik JM
     Application of 3-dimensional reflectance confocal microscopy: Melanocytic proliferations as three-dimensional models.
     J Am Acad Dermatol. 2021;84:1737-1739.
     PubMed    
     
     
     
218. ELSTON D
     This Month in JAAD: June 2021.
     J Am Acad Dermatol. 2021;84:1542.
     PubMed    
     
     
     
219. LONGO C, Mazzeo M, Raucci M, Cornacchia L, et al
     Dark pigmented lesions: Diagnostic accuracy of dermoscopy and reflectance confocal microscopy in a tertiary referral center for skin cancer diagnosis.
     J Am Acad Dermatol. 2021;84:1568-1574.
     PubMed     Abstract available
     
     
     May 2021
220. GREEN AC, Hughes MCB, Williams GM, Malt M, et al
     Increased melanoma recurrence in patients with multiple primary invasive melanomas.
     J Am Acad Dermatol. 2021 May 27. pii: S0190-9622(21)01012.
     PubMed    
     
     
     
221. BITTAR PG, Bittar JM, Etzkorn JR, Brewer JD, et al
     Systematic Review and Meta-Analysis of Local Recurrence Rates of Head and Neck Cutaneous Melanomas after Wide Local Excision, Mohs Micrographic Surgery, or Staged Excision.
     J Am Acad Dermatol. 2021 May 4. pii: S0190-9622(21)00937.
     PubMed     Abstract available
     
     
     
222. CHANG MS, Hartman RI
     Melanoma healthcare and outcome disparities in the Veteran Affairs population.
     J Am Acad Dermatol. 2021 May 4. pii: S0190-9622(21)00938.
     PubMed    
     
     
     April 2021
223. DUNCAN JR, Srikakolapu S, Daugherty A, Elston C, et al
     Cost Efficacy of Wide Local Excision of pT1a Melanoma in Office vs. Operating Room Settings.
     J Am Acad Dermatol. 2021 Apr 28. pii: S0190-9622(21)00920.
     PubMed    
     
     
     
224. GRANT-KELS JM
     JAAD Game Changers: Comparison of surgical margins for lentigo maligna versus melanoma in situ.
     J Am Acad Dermatol. 2021 Apr 21. pii: S0190-9622(21)00887.
     PubMed    
     
     
     
225. MILLER CJ, Etzkorn JR, Leitenberger JJ, Bar A, et al
     Commentary on "Limitations in the literature regarding Mohs surgery and staged excision for melanoma: A critical review of quality and data reporting".
     J Am Acad Dermatol. 2021 Apr 16. pii: S0190-9622(21)00770.
     PubMed    
     
     
     
226. ADALSTEINSSON JA, Stoj VJ, Algzlan H, Swede H, et al
     Limitations in the Literature Regarding Mohs Surgery and Staged Excision for Melanoma: A Critical Review of Quality and Data Reporting.
     J Am Acad Dermatol. 2021 Apr 16. pii: S0190-9622(21)00772.
     PubMed     Abstract available
     
     
     
227. AGGARWAL P, Knabel P, Fleischer AB Jr
     United States Burden of Melanoma and Non-Melanoma Skin Cancer from 1990 to 2019.
     J Am Acad Dermatol. 2021 Apr 11. pii: S0190-9622(21)00755.
     PubMed     Abstract available
     
     
     
228. OLAMIJU B, Suozzi KC, Leffell DJ, Christensen SR, et al
     Clinical Factors Impacting Clear Margins of Primary Melanoma in Situ with Conventional Excision in a Retrospective Cohort.
     J Am Acad Dermatol. 2021 Apr 10. pii: S0190-9622(21)00764.
     PubMed    
     
     
     
229. HEYMANN WR
     Melanoma Healthcare and Outcome Disparities: You Can Never Be Too Rich or Too Thin.
     J Am Acad Dermatol. 2021 Apr 3. pii: S0190-9622(21)00679.
     PubMed    
     
     
     
230. LUKOWIAK TM, Perz AM, Aizman L, Kovell RC, et al
     Mohs micrographic surgery for male genital tumors: Local recurrence rates and patient-reported outcomes.
     J Am Acad Dermatol. 2021;84:1030-1036.
     PubMed     Abstract available
     
     
     
231. WILLIAMS EA, Shah N, Danziger N, Montesion M, et al
     Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms.
     J Am Acad Dermatol. 2021;84:1069-1071.
     PubMed    
     
     
     
232. MURZAKU EC, Shi K, Srivastava D, Nijhawan RI, et al
     Surgical management and practices in pregnancy and lactation: A survey of United States dermatologic surgeons.
     J Am Acad Dermatol. 2021;84:1134-1136.
     PubMed    
     
     
     
233. EASON CD, Rundle C, Dunnick CA, Hugh J, et al
     National trends in free public sunscreen dispensers.
     J Am Acad Dermatol. 2021;84:1109-1111.
     PubMed    
     
     
     March 2021
234. BAYERS S, Orseth M, Prasad S, Hynan LS, et al
     Community-based melanoma screening: A pilot study for the development of an educational curriculum for nonphysician providers.
     J Am Acad Dermatol. 2021 Mar 29. pii: S0190-9622(21)00362.
     PubMed    
     
     
     
235. THOMPSON LL, Chang MS, Polyakov NJ, Blum AE, et al
     Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors.
     J Am Acad Dermatol. 2021 Mar 12. pii: S0190-9622(21)00563.
     PubMed    
     
     
     
236. CULLISON CR, Tripathi R, Bordeaux JS
     Identifying sociodemographic factors associated with hospitalization following primary excision of cutaneous melanoma.
     J Am Acad Dermatol. 2021 Mar 2. pii: S0190-9622(21)00466.
     PubMed    
     
     
     
237. PITNEY T, Muir DJ
     Single-center, single-operator, retrospective analysis of base transection rates in shave procedures for melanoma diagnosis.
     J Am Acad Dermatol. 2021;84:861-862.
     PubMed    
     
     
     
238. MILLER RC, Stewart CR, Lipner SR
     Retrospective study of trends in dermatology telemedicine and in-person visits at an academic center during COVID-19.
     J Am Acad Dermatol. 2021;84:777-779.
     PubMed    
     
     
     February 2021
239. KOBLINSKI JE, Maykowski P, Zeitouni NC
     Disparities in melanoma stage at diagnosis in Arizona: A 10-Year Arizona Cancer Registry Study.
     J Am Acad Dermatol. 2021 Feb 20. pii: S0190-9622(21)00404.
     PubMed    
     
     
     
240. GILLSTEDT M, Hedlund E, Paoli J, Polesie S, et al
     Discrimination between Invasive and In situ Melanomas Using a Convolutional Neural Network.
     J Am Acad Dermatol. 2021 Feb 12. pii: S0190-9622(21)00336.
     PubMed    
     
     
     
241. BRINKER TJ, Schmitt M, Krieghoff-Henning EI, Barnhill R, et al
     Diagnostic performance of artificial intelligence for histologic melanoma recognition compared to 18 international expert pathologists.
     J Am Acad Dermatol. 2021 Feb 10. pii: S0190-9622(21)00331.
     PubMed    
     
     
     
242. GONZALEZ-CAO M, Carrera C, Rodriguez Moreno JF, Rodriguez-Jimenez P, et al
     COVID-19 in Melanoma Patients: Results of the Spanish Melanoma Group Registry, GRAVID study.
     J Am Acad Dermatol. 2021 Feb 10. pii: S0190-9622(21)00337.
     PubMed    
     
     
     
243. STRAKER RJ 3RD, Song Y, Shannon AB, Chu EY, et al
     Association of the Affordable Care Act's Medicaid Expansion with the diagnosis and treatment of clinically localized melanoma: A National Cancer Database Study.
     J Am Acad Dermatol. 2021 Feb 4. pii: S0190-9622(21)00308.
     PubMed     Abstract available
     
     
     
244. VOGEL RI, Jewett PI, Ahmed RL, Lazovich D, et al
     Comparison of sun exposure and protection behaviors between urban and rural residents without a history of melanoma in the Midwestern United States.
     J Am Acad Dermatol. 2021 Feb 3. pii: S0190-9622(21)00304.
     PubMed    
     
     
     
245. LALLAS A, Lallas K, Tschandl P, Kittler H, et al
     The dermoscopic inverse approach significantly improves the accuracy of human readers for lentigo maligna diagnosis.
     J Am Acad Dermatol. 2021;84:381-389.
     PubMed     Abstract available
     
     
     January 2021
246. POLESIE S, Gillstedt M
     Psoriasis and risk of cutaneous melanoma: a retrospective comparative registry-based cohort study.
     J Am Acad Dermatol. 2021 Jan 30. pii: S0190-9622(21)00244.
     PubMed    
     
     
     
247. SCHWAB G, Gerami P, Fiessinger L, Nardone B, et al
     A comparison of the Breslow depth and all-cause survival of male and female genital melanomas.
     J Am Acad Dermatol. 2021 Jan 28. pii: S0190-9622(21)00216.
     PubMed    
     
     
     
248. TAN A, Greenwald E, Bajaj S, Belen D, et al
     Melanoma surveillance for high-risk patients via telemedicine: Examination of real-world data from an integrated store-and-forward total body photography and dermoscopy service.
     J Am Acad Dermatol. 2021 Jan 27. pii: S0190-9622(21)00206.
     PubMed    
     
     
     
249. NADELMAN DA, Ahn JW, VanKoevering KK, Smith NR, et al
     Research Letter: A Single Institution's Review of Patterns of Compliance with Melanoma Ultrasound Surveillance Recommendations.
     J Am Acad Dermatol. 2021 Jan 25. pii: S0190-9622(21)00225.
     PubMed    
     
     
     
250. HU X, Kilgour JM, Fogel AL, Jia JL, et al
     Direct-to-Consumer Genetic Risk Scoring for Melanoma Improves Adherence to Sun-Protective Behaviors Among Increased-Risk Groups: Results from a Prospective U.S. Cohort Study.
     J Am Acad Dermatol. 2021 Jan 18. pii: S0190-9622(21)00191.
     PubMed    
     
     
     
251. VARGAS-MORA P, Peruilh-Bagolini L, Gonzalez-Cuevas R, Ferrer-Rosende P, et al
     Impact of the time interval between primary melanoma excision and sentinel node biopsy: A systematic review and meta-analysis.
     J Am Acad Dermatol. 2021 Jan 16. pii: S0190-9622(21)00162.
     PubMed     Abstract available
     
     
     
252. BHATT MD, Perz AM, Moioli E, Sobanko JF, et al
     The accuracy of detecting melanoma on frozen section MART-1 stains and on permanent sections of previously-frozen tissue: a prospective cohort study.
     J Am Acad Dermatol. 2021 Jan 13. pii: S0190-9622(21)00008.
     PubMed    
     
     
     
253. WEI C, Allais B, Tornberg HN, Quan T, et al
     The utilization of the Altmetric and PlumX scores in evaluating the top 100 trending melanoma articles in social media.
     J Am Acad Dermatol. 2021 Jan 8. pii: S0190-9622(21)00084.
     PubMed    
     
     
     
254. MARSON JW, Maner BS, Harding TP, Meisenheimer J VII, et al
     The Magnitude of COVID-19's Effect on the Timely Management of Melanoma and Non-Melanoma Skin Cancers.
     J Am Acad Dermatol. 2021 Jan 8. pii: S0190-9622(21)00082.
     PubMed    
     
     
     
255. HARTMAN RI, La J, Chang MS, Cheng D, et al
     Risk factors for thick melanoma among Veterans: A cross-sectional study.
     J Am Acad Dermatol. 2021 Jan 7. pii: S0190-9622(21)00086.
     PubMed    
     
     
     
256. MOUSTAFA D, Duncan LM, Hawryluk EB
     A 20-year histopathologic study of pediatric nevi at an academic institution.
     J Am Acad Dermatol. 2021;84:39-40.
     PubMed    
     
     
     
257. LEWINSON RT, Meyers DE, Vallerand IA, Suo A, et al
     Machine learning for prediction of cutaneous adverse events in patients receiving anti-PD-1 immunotherapy.
     J Am Acad Dermatol. 2021;84:183-185.
     PubMed    
     
     
     
258. NAVARRETE-DECHENT C, Liopyris K, Monnier J, Aleissa S, et al
     Reflectance confocal microscopy terminology glossary for melanocytic skin lesions: A systematic review.
     J Am Acad Dermatol. 2021;84:102-119.
     PubMed     Abstract available
     
     
     December 2020
259. SHANNON AB, Sharon CE, Straker RJ 3rd, Miura JT, et al
     The Impact of the COVID-19 Pandemic on the Presentation Status of Newly Diagnosed Melanoma: A Single Institution Experience.
     J Am Acad Dermatol. 2020 Dec 19. pii: S0190-9622(20)33225.
     PubMed    
     
     
     
260. MIGUEL BAF, Morgado-Carrasco D, Toll A, Perez-Anker J, et al
     Meshed keystone flap: A last-step modification to reduce tension and cover a larger surface.
     J Am Acad Dermatol. 2020;83:e397-e398.
     PubMed    
     
     
     November 2020
261. DIKA E, Mastroeni S, Lambertini M, Scarfi F, et al
     The chronic use of multiple photosensitizing drugs is associated with Breslow thickness in female melanoma patients: A bicentric retrospective study.
     J Am Acad Dermatol. 2020 Nov 27. pii: S0190-9622(20)33097.
     PubMed    
     
     
     
262. ALLAIS BS, Beatson M, Wang H, Shahbazi S, et al
     Five-Year Survival in Patients with Nodular and Superficial Spreading Melanomas in the US Population.
     J Am Acad Dermatol. 2020 Nov 27. pii: S0190-9622(20)33094.
     PubMed     Abstract available
     
     
     
263. BARRIOS DM, Do MH, Phillips GS, Postow MA, et al
     Immune checkpoint inhibitors to treat cutaneous malignancies.
     J Am Acad Dermatol. 2020;83:1239-1253.
     PubMed     Abstract available
     
     
     October 2020
264. BEHBAHANI S, Malerba S, Maniar A, Taback B, et al
     Outcomes and Predictors of Survival in Cutaneous Melanoma of the Eyelid: An Analysis of the National Cancer Database.
     J Am Acad Dermatol. 2020 Oct 31. pii: S0190-9622(20)32903.
     PubMed    
     
     
     
265. KELM RC, Ali Y, Orrell K, Rangel SM, et al
     Age and sex differences for malignant melanoma in the pediatric population-childhood versus adolescence: analysis of current nationwide data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program.
     J Am Acad Dermatol. 2020 Oct 24. pii: S0190-9622(20)32862.
     PubMed    
     
     
     
266. NAVARRETE-DECHENT C, Aleissa S, Connolly K, Hibler BP, et al
     Clinical size is a poor predictor of invasion in melanoma of the lentigo maligna type.
     J Am Acad Dermatol. 2020 Oct 20. pii: S0190-9622(20)32835.
     PubMed     Abstract available
     
     
     
267. SISCOS SM, Neill BC, Seger EW, Rajpara A, et al
     Practice habits of Mohs surgeons treating melanoma with Mohs surgery: a cross-sectional survey.
     J Am Acad Dermatol. 2020 Oct 3. pii: S0190-9622(20)32682.
     PubMed    
     
     
     
268. SHI K, Kim D, Mohan LS, Garfield EM, et al
     A retrospective cohort study of the diagnostic value of different subtypes of atypical pigment network on dermoscopy.
     J Am Acad Dermatol. 2020;83:1028-1034.
     PubMed     Abstract available
     
     
     
269. KINSER K, Barlow CE, Leonard D, Farrell SW, et al
     Tanning bed use and depression in a preventive medicine cohort: The Cooper Center Longitudinal Study.
     J Am Acad Dermatol. 2020;83:1200-1202.
     PubMed    
     
     
     
270. YELAMOS O, Manubens E, Jain M, Chavez-Bourgeois M, et al
     Improvement of diagnostic confidence and management of equivocal skin lesions by integration of reflectance confocal microscopy in daily practice: Prospective study in 2 referral skin cancer centers.
     J Am Acad Dermatol. 2020;83:1057-1063.
     PubMed     Abstract available
     
     
     July 2020
271. SOLEYMANI T, Swetter SM, Hollmig ST, Aasi SZ, et al
     Adequacy of conservative 2- to 3-mm surgical margins for complete excision of biopsy-proven severely dysplastic nevi: Retrospective case series at a tertiary academic institution.
     J Am Acad Dermatol. 2020;83:254-255.
     PubMed    
     
     
     June 2020
272. JAFRY MA, Peacock S, Radick AC, Shucard HL, et al
     Pathologists' agreement on treatment suggestions for melanocytic skin lesions.
     J Am Acad Dermatol. 2020;82:1435-1444.
     PubMed     Abstract available
     
     
     May 2020
273. PEREZ-ANKER J, Puig S, Malvehy J
     A fast and effective option for tissue flattening: Optimizing time and efficacy in ex vivo confocal microscopy.
     J Am Acad Dermatol. 2020;82:e157-e158.
     PubMed    
     
     
     April 2020
274. FRIEDMAN BJ, Lee JB
     Spitz nevi in older adults: Correlation of histopathology with results of a gene expression profiling assay.
     J Am Acad Dermatol. 2020;82:1021-1023.
     PubMed    
     
     
     
275. BATCHELDER E, Straight C, Butt M, Kirby JS, et al
     Information framing effects on patients' decisions about dysplastic nevus management.
     J Am Acad Dermatol. 2020;82:1011-1013.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.